Calima Energy Limited

CE1

Calima Energy Ltd. operates as an oil and gas exploration company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2006-07-28. The firm is engaged in the exploration and development of oil and natural gas assets in the Western Canadian Sedimentary Basin. The firm's focuses on maintaining production from the Paradise Field in British Columbia and acquiring additional oil and gas assets.

Coast Entertainment Holdings Limited

CEH

Coast Entertainment Holdings Ltd. engages in the investment and operation of leisure and entertainment businesses. The company is headquartered in North Sydney, New South Wales. The company went IPO on 2018-11-30. The firm owns and operates leisure assets, including Dreamworld, WhiteWater World & SkyPoint theme parks and attractions. The firm operates through the Theme Parks & Attractions segment. The Theme Parks & Attractions segment comprises Dreamworld and WhiteWater World in Coomera, Queensland and the SkyPoint observation deck and climb in Surfers Paradise, Queensland. WhiteWater World includes Wiggle Bay, Pipeline Plunge, Cave of Waves and Cabanas. Dreamworld Theme Parks includes Thrill Rides, Tiger Island, Wildlife Experience and Dreamworld Wildlife Fund (DWF). Its Thrill Rides include the Giant Drop, The Claw, Pandamonium, The Gold Coaster, Tail Spin and Motocoaster. Its SkyPoint includes SkyPoint Observation Deck and Seventy7 Cafe + Bar. Dreamworld is located at the northern end of Queensland’s Gold Coast.

Cardiex Limited

CDX

CardieX Ltd. engages in designing, manufacturing, and marketing medical devices used in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm develops and markets noninvasive patient monitoring technologies for assessing cardiovascular health. The company specializes in the development of biomarkers and digital solutions for large-scale cardiovascular health disorders. Its solutions are designed to be deployed at point-of-care for arterial health screening, and as part of a remote patient monitoring regimen to extend care and enhance cardiovascular health outcomes. Its suite of products includes medical and home health devices and digital solutions for hypertension, cardiovascular disease, and other vascular health disorders all based on the Company’s SphygmoCor vascular biomarker technology. Its products include CONNEQT Pulse, SphygmoCor XCEL, and Oscar 2 Ambulatory Blood Pressure Monitor. CONNEQT Pulse measures both brachial and central blood pressures alongside a suite of vascular biomarkers to provide unparalleled insights into vascular health.